Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & Administrative
Others
Ratios

Bluejay Diagnostics (BJDX) Revenue (2022 - 2023)

Bluejay Diagnostics (BJDX) has disclosed Revenue for 2 consecutive years, with $43235.0 as the latest value for Q3 2023.

  • Quarterly Revenue changed N/A to $43235.0 in Q3 2023 from the year-ago period, while the trailing twelve-month figure was $273683.0 through Dec 2023, down 9.94% year-over-year, with the annual reading at -$839.0 for FY2025, 99.9% up from the prior year.
  • Revenue hit $43235.0 in Q3 2023 for Bluejay Diagnostics, down from $90719.0 in the prior quarter.
  • In the past five years, Revenue ranged from a high of $249040.0 in Q2 2022 to a low of $43235.0 in Q3 2023.